openPR Logo
Press release

United States In-Vitro Diagnostics Market By Segments, Companies, Forecast by 2026

07-05-2021 07:16 AM CET | Health & Medicine

Press release from: Renub Research

/ PR Agency: Renub Research
As per our research findings, United States IVD Industry will further grow with a CAGR of 4.63% during 2020-2026.

As per our research findings, United States IVD Industry will further grow with a CAGR of 4.63% during 2020-2026.

In-vitro diagnostic is an advanced method that provides new tools to find disease diagnosis and treatment. In the United States, the growing prevalence of chronic and infectious diseases has spurred the development of the in-vitro diagnostics (IVD) market. In-vitro diagnostics (IVDs) in the US is considerably more than simple assays conducted in test tubes and examining glass dishes under microscopes. These instruments used to analyze body fluids and tissue samples collected from a patient. The United States In-vitro Diagnostics Market Size was worth US$ 26.9 Billion in 2020.

Besides, the United States In-Vitro Diagnostic market is broad and has various types of diagnostics instruments to perform different techniques. Clinical Chemistry, Microbiology–Molecular, POC–Professional, OTC Diabetes, Immunoassay–Infectious, Histology, Hematology, and Blood Testing are popular IVD techniques in the U.S.A. The growth of POC diagnostic market in the States is phenomenal. These POC diagnostics products have been developed to use at a patient’s bedside in hospitals to get instant results without sending the samples to the lab. Innovations in Microbiology and Immunochemistry diagnostic fields have made these tests economically viable and provide quicker and more precise results.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=united-state-in-vitro-diagnostics-market-p.php

Further In-Vitro diagnostics are used in large-scale population screenings such as for cervical cancer. As well as predicting, whether a particular medicine or therapy would work on a patient. Patients with diabetes use IVDs to test their blood glucose levels regularly. At the same time it is also used to make or confirm a medical diagnosis, such as confirming a pregnancy or testing infectious diseases like HIV or hepatitis. According to Renub Research, United States In Vitro Diagnostics Market will be US$ 35.3 Billion opportunities by 2026.

The United States In-Vitro Diagnostics have a vast product ranges. The reagents segment fastest-growing product in the In-Vitro Diagnostics market as the increasing volume of tests and the rise in R&D initiatives pertaining to reagents. Instrument product is also seen to dominate the market in the forecast period because of rising approval of COVID-19 tests for emergency use by the regulatory authorities. In the United States, the In-vitro diagnostics market is currently in the South of the country, followed by the West being second. As per our research findings, United States IVD Industry will further grow with a CAGR of 4.63% during 2020-2026.

Factors Driving the United States IVD Market

The growth factors like the increasing prevalence of chronic diseases such as heart disease, cancer, asthma, and diabetes are driving the In Vitro Diagnostics market in the United States. Thereon diseases, as mentioned earlier, were responsible for the majority of deaths in the United States, killing over 1.7 million people each year. IVD products used to diagnose and monitor these disorders. As a result, IVDs have proven to be effective in treating and diagnosing several chronic illnesses. However, a lack of effective reimbursement regulations and a shortage of experienced lab technicians are the challenges that are hindering the market's growth.

Coronavirus Impact on IVD Industry of United States

The in-vitro diagnostics industry has seen a huge spurt in demand due to the Covid-19 Pandemic. Primary assays used for COVID-19 detection employ the RT-PCR technique. Although the traditional test takes 5 to 6 hours to produce a result, POC assays (Rapid Antigen Test) have drastically decreased the time. Thus, COVID-19 presents a significant opportunity for the IVD industry's leading stakeholders. As a result, the overall impact of the COVID-19 pandemic on substantial companies in the in vitro diagnostics sector remained positive. Few organizations experiencing a setback due to the lockdown have decreased the amount of regular IVD tests completed across the United States. However, the rapid demand for newly available emergency use permitted IVD tests for COVID-19 detection offsets this negative impact.

Renub Research report titled “United States In Vitro Diagnostics Market, IVD Segments (Clinical Chemistry, Microbiology – Molecular, Microbiology -ID/AST, POC - OTC Diabetes, POC – Professional, POC – Others, Immunoassay – Infectious, Immunoassay – Others, Urinalysis, Histology, Hematology, Molecular - Non Infectious, Coagulation, Blood Testing and Typing, Flow Cytometry), Products (Services, Reagents, Software, Instruments) Regions (Midwest, South, North East West), Companies (Roche Diagnostics, Thermo Fisher Scientific, Siemens Healthineers, Danaher Corporation, Abbott Diagnostics, Sysmex Corporation)” provides a complete analysis of United States In Vitro Diagnostics (IVD) Market.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/united-state-in-vitro-diagnostics-market-p.php

Segments - United States In-Vitro Diagnostics (IVD) Market

1. Clinical chemistry
2. Microbiology -ID/AST
3. Microbiology – Molecular
4. POC – Professional
5. POC - OTC Diabetes
6. POC – Others
7. Immunoassay – Infectious
8. Immunoassay – Others
9. Urinalysis
10. Molecular - Non Infectious
11. Coagulation
12. Histology
13. Hematology
14. Blood Testing and Typing
15. Flow Cytometry

Products - United States In-Vitro Diagnostics (IVD) Market

1. Services
2. Software
3. Reagents
4. Instruments

Regions - United States In-Vitro Diagnostics (IVD) Market

1. South
2. West
3. Midwest
4. North East

All the companies have been studied from three points

• Overview
• Recent Developments
• Sales Analysis

Company covered in this report

1. Roche Diagnostics
2. Abbott Diagnostics
3. Siemens Healthineers
4. Danaher Corporation
5. Thermo Fisher Scientific
6. Sysmex Corporation

Industry Related Opportunity:

France In-Vitro Diagnostics (IVD) Market: https://www.renub.com/france-in-vitro-diagnostics-market-p.php

Saudi Arabia In Vitro Diagnostics (IVD) Market: https://www.renub.com/saudi-arabia-in-vitro-diagnostics-market-p.php

Japan In Vitro Diagnostics (IVD) Market: https://www.renub.com/japan-in-vitro-diagnostics-market-p.php

China In Vitro Diagnostics (IVD) Market: https://www.renub.com/china-in-vitro-diagnostics-market-p.php

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our clients rely on our market analysis and data to make informed knowledgeable decisions. We are regarded as one of the best providers of knowledge. Our pertinent analysis helps consultants, bankers, and executives to make informed and correct decisions.

Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more.

Contact Us:
Renub Research
Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)
Email: info@renub.com
Web: https://www.renub.com
Follow on Linkedin: https://www.linkedin.com/company/renub-research

Roswell, GA 30076

Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today's ultra-competitive markets.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release United States In-Vitro Diagnostics Market By Segments, Companies, Forecast by 2026 here

News-ID: 2320884 • Views: 337

More Releases from Renub Research

United States Alcoholic Beverage Market, Impact of COVID-19, By Type, Companies, …
The alcoholic beverage is a thriving part of the United States economy, owing to its authenticity, flavor, brand and refreshing properties. It has become an essential commodity and is gaining popularity in the trend of socialization with alcohol among young people under 18-29 who is highly inclined to alcohol consumption. The alcoholic beverages industry is composed of companies that manufacture and sell beverages containing alcohol from different sources. The main
Medical Ceramics Market, Impact of COVID-19, By Type of Material, Companies, For …
Nowadays, ceramics have been extremely popular in the manufacturing of medical devices. Advanced ceramics, also called technical ceramics, are becoming more critical in the medical industry. It is a material utilized for various human contact and non-contact applications in the medical industry. These materials are chiefly used to manufacture medical implants, devices, disposables (gloves, vials, tools), and packaging. Medical ceramics are biocompatible and either remain inert or is easily processed
Point of Sale Terminal Market, Impact of COVID-19, By Application, Companies, Fo …
Worldwide, the rapid growth of digital technology in the past few years has expanded the point of sale terminal from just a sales portal into comprehensive payment processing systems that became an integrated part of the entire business operations. A POS terminal is computer software and hardware that manages the transaction by selling a product or a service. It helps to capture, share, store and report data related to the
Epilepsy Drugs Market, Impact of COVID-19, By Drugs Category, Country, Companies …
Globally, millions of people are affected by neurological disorders. In that, over 80% of the death takes place in the low and middle-income countries. Worldwide Epilepsy is the most common neurological disorder, affecting people of all ages. This disease is a chronic brain disorder characterized by sudden and recurrent episodes of seizure. Patients who have epilepsy suffer from sudden behavioral changes, loss of consciousness and severe emotional distress. According to

All 5 Releases


More Releases for IVD

Asia IVD Market
According to a new report published by Allied Market Research, the Asia Pacific In-vitro diagnostics market was valued at $12.9 billion in 2015, and is expected to reach $19.0 billion registering a CAGR of 5.6% during 2016 to 2022. The report offers a detailed analysis of the key segments, top investment pockets, changing dynamics, market size & estimations, and competitive scenario. Download Free Sample Report @ https://www.alliedmarketresearch.com/request-sample/1256 The Asia-Pacific IVD market is
LAMEA IVD Market | Business Development Strategies
LAMEA IVD market size was valued at $7,413 million in 2016, and is projected to reach at $10,316 million by 2023, growing at a CAGR of 4.7% from 2017 to 2023. The immunodiagnostics segment accounted for more than two-ninths share of the total market in 2016. Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/4137 In vitro diagnostics (IVD) are medical devices and reagents used for examination of the body samples such as blood, tissue, and
Global IVD Products Market Research Report
This report studies the global IVD Products market status and forecast, categorizes the global IVD Products market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Abbott Laboratories Danaher Corporation Johnson and Johnson Roche Diagnostics Siemens Healthcare BD Biomerieux Bio-Rad Laboratories Ortho Clinical
Europe IVD Market to Witness $19,124 Million Value by 2023
According to a new report published by Allied Market Research, titled, Europe IVD Market by Product Type, Techniques, Application, and End Users: Global Opportunity Analysis and Industry Forecast, 2017-2023, Europe IVD market was valued at $19,124 million in 2016, and is projected to reach at $26,623 million by 2023, growing at a CAGR of 4.7% from 2017 to 2023. In vitro diagnostic tests are performed using biological samples to detect the
Global IVD Reagents Market Applications & Strategies, 2022
Qyresearchreports include new market research report "Global IVD Reagents Market Research Report 2017" to its huge collection of research reports. The market study on the global IVD Reagents market is a professional tool that scrutinizes vital market indicators to understand the progression of the said between 2017-2022. The research report on the global IVD Reagents market studies historical and current performance, which are used to provide projections for crucial market indices.
IVD Market– Projections & Estimations, 2017–2023
Big Market Research added a report on “IVD Market By Product Type (Reagents, Instruments And Software & Services), By Technique (Immunodiagnostics, Blood Testing, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, And Other IVD Techniques), By Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, And Other Indications), And By End Users (Standalone Laboratory, Hospitals, Academic And Medical Schools, Point Of Care Testing, And Others) - Global Opportunity